SAR288 has emerged as a potential therapeutic target for COVID-19. This drug compound exhibits significant antiviral activity against SARS-CoV-2, the virus responsible for COVID-19. Preclinical studies have https://oisicqcz677273.mpeblog.com/68532100/a-novel-therapeutic-target-for-covid-19